
Peptides
Subcategories of "Peptides"
Found 29779 products of "Peptides"
RP13-102H20.1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RP13-102H20.1 antibody, catalog no. 70R-7538
Purity:Min. 95%Sar1, Ile4,8]-Angiotensin II
CAS:Sar1, Ile4,8]-Angiotensin II is a peptide that belongs to the class of angiotensins. It has been shown to activate angiotensin receptors and is used as a research tool in pharmacology and cell biology. Sar1, Ile4,8]-Angiotensin II interacts with ligands such as heparin-binding EGF-like growth factor (HB-EGF) and angiopoietin 1 (ANGPT1). The antibody against Sar1, Ile4,8]-Angiotensin II blocks the receptor binding activity of this peptide. Sar1, Ile4,8]-Angiotensin II has been shown to be an inhibitor of ion channels such as inward rectifier potassium channels.
Formula:C43H75N13O9Purity:Min. 95%Molecular weight:918.14 g/molRAD51AP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RAD51AP1 antibody, catalog no. 70R-4861
Purity:Min. 95%ZNF318 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF318 antibody, catalog no. 70R-7934
Purity:Min. 95%ADAMTS4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADAMTS4 antibody, catalog no. 70R-2304
Purity:Min. 95%NDUFV1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NDUFV1 antibody, catalog no. 70R-1114
Purity:Min. 95%Scg2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Scg2 antibody, catalog no. 70R-8629
Purity:Min. 95%SLC4A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC4A1 antibody, catalog no. 70R-2370
Purity:Min. 95%Bis-dPEG®5-Acid
CAS:Bis-dPEG®5-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®5-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.
Formula:C12H18O5SPurity:Min. 95%Molecular weight:274.33 g/molVimentin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VIM antibody, catalog no. 70R-3030
Purity:Min. 95%4-Formyl-Benzamido-dPEG®24-TFP Ester
4-Formyl-Benzamido-dPEG®24-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. 4-Formyl-Benzamido-dPEG®24-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Formula:C65H107F4NO28Purity:Min. 95%Molecular weight:1,426.53 g/molLRRC51 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC51 antibody, catalog no. 70R-3794
HNRPLL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HNRPLL antibody, catalog no. 70R-4841
Purity:Min. 95%SARS Spike (306-515), Sf9
SARS Coronavirus is an enveloped virus containing 3 outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein takes part in the virus infection cycle and is the primary target of neutralizing antibodies. SARS Spike produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 219 amino acids (306-515 aa) and having a molecular mass of 24.7kDa.SARS Spike is fused to a 6 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques. The formulation of the SARS Spike (306-515) solution (0.5mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol. Biological Activity: Measured by its binding ability in a functional ELISA with Human ACE-2 (CAT# enz-1159).
One-Letter Formula: ADPRVVPSGD VVRFPNITNL CPFGEVFNAT KFPSVYAWER KKISNCVADY SVLYNSTFFS TFKCYGVSAT KLNDLCFSNV YADSFVVKGD DVRQIAPGQT GVIADYNYKL PDDFMGCVLA WNTRNIDATS TGNYNYKYRY LRHGKLRPFE RDISNVPFSP DGKPCTPPAL NCYWPLNDYG FYTTTGIGYQ PYRVVVLSFE LLNAPATVCG PKLHHHHHHPurity:Min. 95%Fmoc-N-Amido-dPEG®6-Acid
CAS:Fmoc-N-Amido-dPEG®6-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Fmoc-N-Amido-dPEG®6-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Formula:C30H41NO10Purity:Min. 95%Molecular weight:575.65 g/molSFRS8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SFRS8 antibody, catalog no. 70R-1424
Purity:Min. 95%KCNH5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNH5 antibody, catalog no. 70R-1523
Purity:Min. 95%Bis-MAL-dPEG®11
CAS:Bis-MAL-dPEG®11 is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-MAL-dPEG®11 is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.
Formula:C65H105F4N9O21S2Purity:Min. 95%Molecular weight:1,488.7 g/molSERINC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SERINC2 antibody, catalog no. 70R-9351
Purity:Min. 95%[D-Ala2,Met5]-Enkephalinamide
CAS:D-Ala2,Met5]-Enkephalinamide is a potent endogenous opioid peptide that binds to opioid receptors and has been shown to have both antinociceptive and depressant effects. It has been shown to be effective in a model system of pain, acting on the descending antinociceptive pathway from the rostral ventromedial medulla (RVM) to the spinal cord. D-Ala2,Met5]-Enkephalinamide has also been observed to inhibit locomotor activity in CD1 mice at sub-effective doses. D-Ala2,Met5]-Enkephalinamide has been shown to act through activation of both G protein-coupled mu opioids receptors and G protein-coupled delta opioid receptors.
Formula:C28H38N6O6S•CH3COOH•H2OPurity:Min. 95%Molecular weight:664.77 g/mol
